Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation
Open Access
- 31 July 2006
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 187 (1) , 191-197
- https://doi.org/10.1016/j.atherosclerosis.2005.09.012
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patientsAtherosclerosis, 2005
- C-Reactive Protein Levels and Outcomes after Statin TherapyNew England Journal of Medicine, 2005
- Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndromeAtherosclerosis, 2004
- High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefitAmerican Heart Journal, 2004
- Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patientsAtherosclerosis, 2003
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Thrombogenic Factors and Recurrent Coronary EventsCirculation, 1999
- C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial InfarctionCirculation, 1998
- Epidemiological aspects of high density lipoprotein cholesterolAtherosclerosis, 1998